| Document Date: 2011-06-01 14:34:51
Open Document File Size: 528,39 KBShare Result on Facebook
City Reference / / Company SUSPECTED ADVERSE REACTIONS / Schering Corporation / Merck & Co. Inc. / / Facility Laboratory Test Interactions ADVERSE REACTIONS / / Holiday between Day / / IndustryTerm insertion site / magnetic resonance imaging / herbal products / healthcare / healthcare providers performing insertions / antiseptic solution / contraceptive products / healthcare providers / / MedicalCondition venous and arterial thromboembolism / ectopic pregnancy / strokes / allergies / vaginitis / Allergic reaction / lower abdominal pain / Gallbladder Disease / headache / varian Cysts / sterility / Carcinoma / thromboembolic disorders / breast pain / vascular injury / Liver tumors / injury / Ectopic pregnancies / miscarriage / pulmonary embolism / Liver Disease / increase breakthrough bleeding / infections / breast cancer / abdominal pain / suspected breast cancer / acne / Carcinogenesis / deep venous thrombosis / progestin-sensitive cancer / active liver disease / retinal vein thrombosis / Pain / blister / myocardial infarction / deep vein thrombosis / pulmonary emboli / venous thromboembolism / myocardial infarctions / infection / thrombosis / neural injury / paresthesias / pharyngitis / / MedicalTreatment oral contraceptives / incision / contraceptive method / surgery / contraception / / Organization Center for Disease Control / DOSAGE AND ADMINISTRATION / FDA / / / Position Counsel / / Product IMPLANON / lidocaine / / Technology X-ray / tomography / ultrasound / at the insertion site / MRI / Pharmacokinetics / magnetic resonance imaging / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXPLANON safely and effectively. See full prescribing information for NEXPLANON. •